← Back to Search

Videoscope-Assisted Surgery for Gum Disease

N/A
Recruiting
Led By Salvador Nares, DDS, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Vital tooth or previous root canal therapy with no signs/symptoms of pathology
Individuals presenting with at least 1 single or multirooted tooth with residual, isolated, interproximal bony defect with probing depths (PD) ≥ 6 mm, clinical attachment loss (CAL) ≥ 6mm, bleeding upon probing (BOP), and ≥ 2mm width of attached gingiva (WAG)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing whether the use of a videoscope to improve visualization of the surgical field during minimally invasive surgery for periodontitis results in better clinical and radiographic outcomes compared to standard minimally invasive surgery and guided tissue regeneration.

Who is the study for?
This trial is for systemically healthy adults aged 18-70 with severe chronic periodontitis, evidenced by specific dental measurements and radiographs. Candidates must have good oral hygiene (plaque scores ≤20%) and be English-speaking to follow study procedures. Excluded are pregnant women, smokers, those on certain medications or with systemic disorders affecting healing, and individuals with non-isolated gum disease or certain dental restorations.Check my eligibility
What is being tested?
The study tests if using a videoscope during minimally invasive surgery improves outcomes in treating severe gum disease compared to standard methods. Participants will be randomly assigned to one of three groups: videoscope-assisted surgery (test), traditional minimally invasive surgery (control 1), or guided tissue regeneration (control 2). Outcomes will be measured through digital radiographs and fluid analysis over a year.See study design
What are the potential side effects?
While the document does not specify side effects, typical risks of periodontal surgeries may include discomfort, swelling, bleeding, infection risk at the surgical site, temporary increased tooth sensitivity or mobility.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My teeth are healthy or successfully treated with no current issues.
Select...
I have a tooth with gum disease showing deep cleaning needs, bleeding, and enough gum attachment.
Select...
I am between 18 and 70 years old.
Select...
I am generally healthy with no or mild systemic disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Attachment Level
Gingival Recession (GR)
Probing Depth (PD)
+2 more
Secondary outcome measures
Gingival Crevicular Fluid (GCF) Growth Factor and Cytokine/Chemokine Levels

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Videoscope-assisted periodontal regeneration minimally invasive surgeryExperimental Treatment1 Intervention
Videoscope-assisted periodontal regeneration minimally invasive surgery - Test group
Group II: Guided tissue regeneration surgeryActive Control1 Intervention
Guided tissue regeneration - Control Group 2
Group III: Periodontal regeneration minimally invasive surgeryActive Control1 Intervention
Periodontal regeneration minimally invasive surgery - Control Group 1

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
608 Previous Clinical Trials
1,559,455 Total Patients Enrolled
Salvador Nares, DDS, PhDPrincipal InvestigatorUniversity of Illinois at Chicago

Media Library

Guided tissue regeneration surgery Clinical Trial Eligibility Overview. Trial Name: NCT05275192 — N/A
Gum Disease Research Study Groups: Guided tissue regeneration surgery, Videoscope-assisted periodontal regeneration minimally invasive surgery, Periodontal regeneration minimally invasive surgery
Gum Disease Clinical Trial 2023: Guided tissue regeneration surgery Highlights & Side Effects. Trial Name: NCT05275192 — N/A
Guided tissue regeneration surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05275192 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a current call for individuals to join the trial?

"According to the clinicaltrials.gov listing, this trial is actively seeking participants since first posting on May 1st 2022 and last updated 24th of that same month."

Answered by AI

Who is the ideal candidate for this clinical research?

"This clinical trial is searching for 50 English-speaking individuals, aged 18 to 70 years old, that have been diagnosed with chronic periodontitis. Eligible participants must meet the following criteria: be of American Society of Anesthesiologists (ASA) I or II health rating; present a single or multirooted tooth with residual interproximal bony defect featuring probing depths (PD) ≥ 6 mm, clinical attachment loss (CAL) ≥ 6mm and bleeding upon probing (BOP); display >2mm width attached gingiva on radiographs taken within 2 years of enrolment; display plaque score ≤20%;"

Answered by AI

How many participants will be enrolled in this research trial?

"Affirmative. According to the information on clinicaltrials.gov, this investigation is currently seeking participants with its first post dating back to May 1st 2022 and its most recent edit occurring on May 24th 2022. In total, 50 test subjects need to be recruited from one location."

Answered by AI

Is the age of 55 or older a prerequisite to partake in this investigation?

"According to the given inclusion criteria, only those between 18 and 70 years old can take part in this experiment. For minors and senior citizens there are alternative clinical trials with 4 studies for under-18s and 71 for people over 65."

Answered by AI
~0 spots leftby Apr 2024